BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26462468)

  • 1. Soluble αKlotho as a candidate for the biomarker of aging.
    Koyama D; Sato Y; Aizawa M; Maki T; Kurosawa M; Kuro-o M; Furukawa Y
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1019-25. PubMed ID: 26462468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
    Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
    Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
    J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
    Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
    Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
    J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation.
    Mizia-Stec K; Wieczorek J; Polak M; Wybraniec MT; Woźniak-Skowerska I; Hoffmann A; Nowak S; Wikarek M; Wnuk-Wojnar A; Chudek J; Więcek A
    Cytokine; 2018 Nov; 111():106-111. PubMed ID: 30138898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
    Tartaglione L; Pasquali M; Rotondi S; Muci ML; Leonangeli C; Farcomeni A; Fassino V; Mazzaferro S
    PLoS One; 2017; 12(5):e0178637. PubMed ID: 28558021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes.
    Fountoulakis N; Maltese G; Gnudi L; Karalliedde J
    J Clin Endocrinol Metab; 2018 May; 103(5):2026-2032. PubMed ID: 29509906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.
    Efthymiadou A; Kritikou D; Mantagos S; Chrysis D
    Eur J Endocrinol; 2016 Apr; 174(4):473-9. PubMed ID: 26764419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
    Seiler S; Wen M; Roth HJ; Fehrenz M; Flügge F; Herath E; Weihrauch A; Fliser D; Heine GH
    Kidney Int; 2013 Jan; 83(1):121-8. PubMed ID: 22895520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V; Pelletier S; Dubourg L; Drai J; Cuerq C; Lemoine S; Hadj-Aissa A; Laville M; Fouque D
    J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels.
    Poelzl G; Ghadge SK; Messner M; Haubner B; Wuertinger P; Griesmacher A; Doerler J; Ensinger C; Ulmer H; Zaruba MM
    Sci Rep; 2018 May; 8(1):8429. PubMed ID: 29849175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and Klotho.
    Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
    J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum αKlotho as a Predictor of Graft Dysfunction After Kidney Transplantation.
    Tsujita M; Kosugi T; Masuda T; Okada M; Futamura K; Hiramitsu T; Goto N; Shunji N; Watarai Y; Maruyama S
    Transplant Proc; 2018 Dec; 50(10):3440-3444. PubMed ID: 30577218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
    Bacchetta J; Dubourg L; Harambat J; Ranchin B; Abou-Jaoude P; Arnaud S; Carlier MC; Richard M; Cochat P
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.